(5-((2-Chlorophenoxy)methyl)furan-2-yl)(4-methylpiperidin-1-yl)methanone
98%
- Product Code: 130047
CAS:
494858-37-6
| Molecular Weight: | 333.81 g./mol | Molecular Formula: | C₁₈H₂₀ClNO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 482.4±40.0 °C(Predicted) | |
| Density: | 1.218±0.06 g/cm3(Predicted) | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
Used primarily in the development of pharmaceutical agents, this compound serves as a key intermediate in the synthesis of bioactive molecules targeting central nervous system disorders. Its structural features enable interaction with neurological receptors, making it valuable in the research of anxiolytic and anticonvulsant drugs. The furan and chlorophenoxy components contribute to enhanced metabolic stability and receptor binding affinity. Additionally, it has been explored in the design of selective enzyme inhibitors for inflammatory pathways, showing potential in early-stage drug discovery programs. Its piperidine moiety allows for favorable pharmacokinetic properties, supporting oral bioavailability in preclinical candidates.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | $808.69 |
+
-
|
| 250mg | 10-20 days | $1,373.60 |
+
-
|
(5-((2-Chlorophenoxy)methyl)furan-2-yl)(4-methylpiperidin-1-yl)methanone
Used primarily in the development of pharmaceutical agents, this compound serves as a key intermediate in the synthesis of bioactive molecules targeting central nervous system disorders. Its structural features enable interaction with neurological receptors, making it valuable in the research of anxiolytic and anticonvulsant drugs. The furan and chlorophenoxy components contribute to enhanced metabolic stability and receptor binding affinity. Additionally, it has been explored in the design of selective enzyme inhibitors for inflammatory pathways, showing potential in early-stage drug discovery programs. Its piperidine moiety allows for favorable pharmacokinetic properties, supporting oral bioavailability in preclinical candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :